Literature DB >> 2538064

Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin.

F Scamps1, A Undrovinas, G Vassort.   

Abstract

The effects of four class I antiarrhythmic compounds on the Ca current (ICa), recorded with whole cell patch clamp in single isolated frog ventricular cells, were compared. Na and K currents were blocked by tetrodotoxin and Cs. Quinidine and flecainide induced an apparent tonic block with a 50% effective dose (ED50) at 10 and 20 microM, respectively; there was no clear use-dependent inhibition. Ethmozin and ethacizin, two phenothiazine derivatives, exhibited both tonic and use-dependent inhibition. Ethacizin was at least 10 times more potent than ethmozin; at 1 microM, it induced a 15% tonic block and 5, 35, and 42% use-dependent block at 0.125, 1, and 2 Hz, respectively. These compounds appeared only 3- to 10-fold less efficient on the ICa than on the Na current recorded in parallel experiments, with flecainide showing the largest different potency. All four compounds shifted the availability curves by a few millivolts toward hyperpolarization, had a clear voltage-dependent inhibition, and slowed reactivation, the latter effect being more marked with less negative holding potential. Consequently, the absence of use-dependence inhibition with quinidine and flecainide could be the consequence of a very fast association of the two compounds with the open channels that would be complete during the 200-ms depolarizing pulse. Since arrhythmias are frequently associated with tissue depolarization and can be related to Ca-dependent action potential and slow conduction, the inhibition of the ICa reported above should account, in part, both for the antiarrhythmic and the negative inotropic effects of these compounds.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538064     DOI: 10.1152/ajpcell.1989.256.3.C549

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Potentiation of cardiodepressive action among calcium antagonists from different classes: evidence for a mechanism at the single calcium channel level.

Authors:  S Braun; N Frey; S Herzig; C Hilbert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

3.  A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms.

Authors:  Jonathan D Moreno; Z Iris Zhu; Pei-Chi Yang; John R Bankston; Mao-Tsuen Jeng; Chaoyi Kang; Lianguo Wang; Jason D Bayer; David J Christini; Natalia A Trayanova; Crystal M Ripplinger; Robert S Kass; Colleen E Clancy
Journal:  Sci Transl Med       Date:  2011-08-31       Impact factor: 17.956

4.  Effects of blockade of fast and slow inward current channels on ventricular fibrillation in the pig heart.

Authors:  A J Stewart; J D Allen; A B Devine; A A Adgey
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

5.  Use-dependent block of Ca2+ current by moricizine in guinea-pig ventricular myocytes: a possible ionic mechanism of action potential shortening.

Authors:  T Yamane; A Sunami; T Sawanobori; M Hiraoka
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  The effects of flecainide on ATP-sensitive K(+) channels in pig urethral myocytes.

Authors:  T Yunoki; N Teramoto; S Naito; Y Ito
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

7.  Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

Authors:  B F del Pozo; F Pérez-Vizcaíno; E Villamor; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig.

Authors:  L Fei; J S Gill; W J McKenna; A J Camm
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.

Authors:  Jonathan D Moreno; Pei-Chi Yang; John R Bankston; Eleonora Grandi; Donald M Bers; Robert S Kass; Colleen E Clancy
Journal:  Circ Res       Date:  2013-07-29       Impact factor: 17.367

10.  Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.

Authors:  Ashok A Paul; Harry J Witchel; Jules C Hancox
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.